Mika Kamata-Sakurai

3PUBLICATIONS
48CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Apr 01, 2024
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer.

Hirofumi Mikami, Shu Feng, Yutaka Matsuda

|Aug 28, 2020
Antibody to CD137 Activated by Extracellular Adenosine Triphosphate Is Tumor Selective and Broadly Effective In Vivo without Systemic Immune Activation.

Mika Kamata-Sakurai, Yoshinori Narita, Yuji Hori

|Oct 06, 2017
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors.

Takahiro Ishiguro, Yuji Sano, Shun-Ichiro Komatsu

Pageof 1

Frequent Collaborators

2 joint publications

Tetsuya Wakabayashi

2 joint publications

Tomoyuki Igawa

2 joint publications

Yoshiki Kawabe

1 joint publications

Takahiro Ishiguro